Back to Newsroom

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2017 Financial Results

BERKELEY HEIGHTS, N.J., March 21, 2018 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) (“Cyclacel” or the “Company”), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, will announce fourth quarter and full year 2017 financial results on Wednesday, March 28, 2018. The Company will host a conference call and live webcast at 4:30 p.m. Eastern Time on the same day.
READ MORE…